Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Revenues
Revenues	$ 3,170	$ 2,360
Cost of revenues
Cost of revenues	1,624	1,191
Gross profit	1,546	1,169
Operating expenses
Sales and marketing	496	405
Research and development	437	377
General and administrative	115	109
Transaction and loan losses	116	75
Total operating expenses	1,164	966
Income from operations	382	203
Other expense, net
Interest income	75	65
Net realized gain on equity and other investments	3	0
Net unrealized loss on equity and other investments	(1,064)	(1,021)
Net loss on equity method investment	(21)	(23)
Foreign exchange (loss) gain	(9)	6
Total other expense, net	(1,016)	(973)
Loss before income taxes	(634)	(770)
Recovery of income taxes	53	88
Net loss	$ (581)	$ (682)
Net loss per share attributable to shareholders:
Basic (in dollars per share)	$ (0.45)	$ (0.53)
Diluted (in dollars per share)	$ (0.45)	$ (0.53)
Weighted average shares used to compute net loss per share attributable to shareholders:
Basic (in shares)	1,303,357,874	1,295,377,376
Diluted (in shares)	1,303,357,874	1,295,377,376
Other comprehensive (loss) income
Unrealized gain (loss) on cash flow hedges	$ (7)	$ 5
Tax effect on unrealized gain (loss) on cash flow hedges	2	(1)
Total other comprehensive (loss) income	(5)	4
Comprehensive loss	(586)	(678)
Subscription solutions
Revenues
Revenues	750	620
Cost of revenues
Cost of revenues	148	123
Merchant solutions
Revenues
Revenues	2,420	1,740
Cost of revenues
Cost of revenues	$ 1,476	$ 1,068

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash flows from operating activities
Net loss for the period	$ (581)	$ (682)
Adjustments to reconcile net loss to net cash provided by operating activities:
Amortization and depreciation	7	8
Stock-based compensation	132	114
Provision for transaction and loan losses	48	43
Deferred income tax recovery	(139)	(129)
Revenue related to non-cash consideration	(12)	(13)
Net loss on equity and other investments	1,061	1,021
Net loss on equity method investment	21	23
Unrealized foreign exchange loss (gain)	14	(12)
Changes in operating assets and liabilities	(70)	(6)
Net cash provided by operating activities	481	367
Cash flows from investing activities
Purchases of property and equipment	(5)	(4)
Purchases of marketable securities	(843)	(1,718)
Maturities of marketable securities	1,463	1,331
Purchases and originations of loans	(1,349)	(805)
Repayments and sales of loans	1,043	637
Purchases of equity and other investments	(1)	(4)
Acquisition of businesses, net of cash acquired	0	(56)
Other	2	0
Net cash provided by (used in) investing activities	310	(619)
Cash flows from financing activities
Proceeds from the exercise of stock options	6	59
Repurchases of common stock	(491)	0
Net cash (used in) provided by financing activities	(485)	59
Effect of foreign exchange on cash, cash equivalents and restricted cash	(3)	4
Net increase (decrease) in cash, cash equivalents and restricted cash	303	(189)
Cash, cash equivalents and restricted cash – beginning of period	1,545	1,498
Cash, cash equivalents and restricted cash – end of period	1,848	1,309
Supplemental cash flow information:
Cash paid for income taxes, net	$ 93	$ 27

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2026	Dec. 31, 2025
Current assets
Cash and cash equivalents	$ 1,848	$ 1,545
Marketable securities	3,895	4,233
Trade and other receivables, net	449	500
Loans and merchant cash advances, net	2,097	1,784
Other current assets	206	234
Total current assets	8,495	8,296
Long-term assets
Property and equipment, net	54	53
Operating lease right-of-use assets, net	84	88
Intangible assets, net	28	30
Deferred tax assets	117	33
Other long-term assets	30	39
Long-term investments	708	975
Equity and other investments ($2,563 and $3,619, carried at fair value)	3,533	4,582
Equity method investment	581	602
Goodwill	491	491
Total long term assets	5,626	6,893
Total assets	14,121	15,189
Current liabilities
Accounts payable and accrued liabilities	1,034	1,075
Deferred revenue	321	300
Operating lease liabilities	16	17
Total current liabilities	1,371	1,392
Long-term liabilities
Deferred revenue	86	98
Operating lease liabilities	163	171
Deferred tax liabilities	0	55
Total long term liabilities	249	324
Contingencies (Note 8)
Equity, Attributable to Parent [Abstract]
Common stock, unlimited Class A subordinate voting shares authorized, 1,222,705,445 and 1,225,830,706, issued and outstanding; unlimited Class B restricted voting shares authorized, 78,073,584 and 78,073,594 issued and outstanding; 1 Founder share authorized, 1 and 1 issued and outstanding	9,971	10,376
Additional paid-in capital	255	236
Accumulated other comprehensive (loss) income	(4)	1
Accumulated surplus	2,279	2,860
Total shareholders’ equity	12,501	13,473
Total liabilities and shareholders’ equity	$ 14,121	$ 15,189